| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard Giroux | CFO;COO | 2026-07-21 | 56,000 | $12.51 | $700.56kSell |
| Stuart Naylor | CHIEF SCI OFCR OPHTHALMOLOGY | 2026-07-07 | 2,547 | $13.86 | $35.30kSell |
| Stuart Naylor | CHIEF SCI OFCR OPHTHALMOLOGY | 2026-07-07 | 25,112 | $14.90 | $374.17kSell |
| Alexandria Forbes | PRESIDENT CEO | 2026-05-19 | 62,000 | $9.17 | $568.54kSell |
| Richard Giroux | CFO COO | 2026-04-21 | 56,000 | $10.22 | $572.32kSell |
| Perceptive Advisors LLC | Director | 2026-04-17 | 555,555 | $9.00 | $5.00MBuy |
| Stuart Naylor | CHIEF DEV. OFFICER | 2026-04-07 | 27,661 | $9.36 | $258.91kSell |
| Alexandria Forbes | PRESIDENT CEO | 2026-03-24 | 62,000 | $7.41 | $459.42kSell |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | 2026-02-21 | 2,952 | $7.45 | $21.99kSell |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | 2026-02-21 | 5,949 | $7.45 | $44.32kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sanofi | 12.70% | 12,197,737 | $169.43M | Insider |
| Perceptive Advisors LLC | 11.23% | 10,786,658 | $149.83M | Insider |
| Johnson Johnson | 6.91% | 6,641,064 | $92.24M | Insider |
| Johnson Innovatio Johnson | 6.91% | 6,641,064 | $92.24M | Insider |
| Perceptive Life Sciences Master Fund Ltd | 6.26% | 6,007,746 | $83.45M | Insider |
| Joel S. Marcus | 2.16% | 2,070,608 | $28.76M | Insider |
| Alexandria Forbes | 1.66% | 1,593,704 | $22.14M | Insider |
| Richard Giroux | 1.15% | 1,099,956 | $15.28M | Insider |
| Stuart Naylor | 0.67% | 640,846 | $8.90M | Insider |
| Keith R. Harris | 0.21% | 200,000 | $2.78M | Insider |